Loading...
Back to narrative

Update shared on10 Oct 2025

Fair value Decreased 1.28%
AnalystConsensusTarget's Fair Value
€19.26
21.9% undervalued intrinsic discount
10 Oct
€15.04
Loading
1Y
-25.3%
7D
-3.3%

The analyst price target for CVC Capital Partners has been slightly lowered to €19.26, as analysts factor in a modest reduction in growth estimates while also considering continued profitability.

Analyst Commentary

Recent updates from major research firms have highlighted both optimism and caution regarding CVC Capital Partners' outlook. Analysts are weighing the company's current profitability against its growth trajectory and market conditions.

Bullish Takeaways

  • Bullish analysts continue to raise their price targets, which reflects confidence in CVC Capital Partners' resilience in maintaining profitability.
  • Growth estimates, while modestly reduced, remain strong enough to support increased valuations as price targets move higher.
  • The retention of Overweight ratings signals that institutions still see CVC as well-positioned compared to peers in the sector.
  • Positive adjustments to price targets suggest analysts believe CVC can effectively execute on its business plan despite encountering a more challenging macro environment.

Bearish Takeaways

  • Although price targets have increased, the extent of these changes has been relatively small and points to some caution about the pace of future growth.
  • Bearish analysts note that the modest reduction in growth estimates could put pressure on valuation if profitability trends do not continue.
  • Cautious sentiment remains regarding potential headwinds in the broader market, which could affect execution and future earnings.

What's in the News

  • CVC Capital Partners has begun refinancing its sports assets portfolio valued at over $12 billion (Bloomberg).
  • CVC Capital Partners plc was added to the Amsterdam AEX Index.
  • CVC Capital Partners exited the bidding process for acquiring Australian money lender La Trobe Financial after regulatory complications and competitor withdrawal.
  • The private equity firm is considering buying a stake in Indian investment company Avendus Capital Pvt. after another bidder dropped out.
  • CVC Capital Partners is exploring a sale of its stake in PT Soho Global Health Tbk, a transaction that could value the Indonesian company at about $650 million.

Valuation Changes

  • Consensus Analyst Price Target has decreased slightly from €19.51 to €19.26, reflecting a small adjustment in fair value estimates.
  • Discount Rate has risen modestly from 7.43 percent to 7.49 percent. This indicates a marginal increase in perceived risk or required return.
  • Revenue Growth projections have fallen from 9.14 percent to 8.28 percent. This suggests a more cautious outlook on future expansion.
  • Net Profit Margin has increased marginally from 55.06 percent to 55.57 percent. This indicates slight improvements in anticipated profitability.
  • Future P/E has edged higher from 20.29x to 20.35x. This shows a minor increase in expected valuation multiples.

Disclaimer

AnalystConsensusTarget is a tool utilizing a Large Language Model (LLM) that ingests data on consensus price targets, forecasted revenue and earnings figures, as well as the transcripts of earnings calls to produce qualitative analysis. The narratives produced by AnalystConsensusTarget are general in nature and are based solely on analyst data and publicly-available material published by the respective companies. These scenarios are not indicative of the company's future performance and are exploratory in nature. Simply Wall St has no position in the company(s) mentioned. Simply Wall St may provide the securities issuer or related entities with website advertising services for a fee, on an arm's length basis. These relationships have no impact on the way we conduct our business, the content we host, or how our content is served to users. The price targets and estimates used are consensus data, and do not constitute a recommendation to buy or sell any stock, and they do not take account of your objectives, or your financial situation. Note that AnalystConsensusTarget's analysis may not factor in the latest price-sensitive company announcements or qualitative material.